Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06604325 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06604325 · ClinicalTrials.gov record · last posted 2024-10-24

Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.

StatusRecruiting
PhaseNot applicable
Started2024-10-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 24, 2024 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality. Globally, it is responsible for 25% of all pregnancy-related deaths. PPH is unpredictable and may occur in the absence of risk factors. Tranexamic acid is an antifibrinolytic proven to reduce blood loss and transfusion requirements for various surgeries. This study aims to explore the effectiveness of tranexamic acid as an adjunct to other uterotonics before the Caesarian Section.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-09-17. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-10-22
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT06604325
Lead Sponsor Aligarh Muslim University
Conditions Post Partum Hemorrhage
Enrollment 300 participants
Start Date 2024-10-01
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-24